difference between dulaglutide and semaglutide Dosing Patterns of in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort Study | Advances in Therapy Semaglutide Shows Comparable Glycemic Control

2023, doi: 10.1007/s12630-023-02549-5

Serum amylase levels in relation to islet Cell function in patients with early type 2 diabetes

UK product information advises that patients should: Recognise symptoms of pancreatitis (severe, persistent abdominal pain radiating to the back, nausea, vomiting) Seek immediate medical attention if these symptoms develop Discontinue the medicine if pancreatitis is suspected Not restart the GLP-1 medicine if pancreatitis is confirmed Patients should also be aware of an increased risk of gallbladder disease (gallstones, cholecystitis) with GLP-1 medicines, which can present with similar abdominal symptoms and requires prompt medical attention

found that ASCT2 ligands chloroalanine, aminooxetane-3-carboxylate (AOC), and -FBP also inhibit ASCT2-mediated glutamine uptake in human melanoma cells [104]

Inflammation, HIF-1, and the epigenetics that follows

another was more energetic and attentive